相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

解码遗传题:胰腺神经内分泌瘤关键驱动基因的突变

Huanchang Jiang¹, Wuhu Zhang¹, Xiaowu Xu¹

¹Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Shanghai Pancreatic Cancer Institute, Shanghai 200032, China; Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai 200032, China; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.

Biochimica et biophysica acta. Reviews on cancer

|March 30, 2025

概括

胰腺神经内分泌瘤 (PanNETs) 有不同的遗传特征,包括MEN1,ATRX,DAXX和VHL的突变. 了解这些遗传变异有助于开发有针对性的疗法,以改善患者的治疗结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

胰腺神经内分泌瘤 (PanNETs) 很少见,但具有独特的临床和遗传特征.
测序技术的进步提高了对PanNET分子通路的理解.

研究的目的:

通过检查关键的遗传突变,审查泛网的病变发生.
澄清这些突变对潜在治疗策略的临床相关性.

主要方法:

对PanNET遗传学和分子通路的当前文献的综述.
对经常发生突变的基因进行分析,包括MEN1,ATRX,DAXX,VHL,PTEN,TSC1/TSC2和AKT1-3.3.

主要成果:

MEN1突变会影响瘤抑制器menin,影响基因调节和DNA修复.
通过ALT途径,ATRX和DAXX的改变与染色质重塑,端粒稳定性和瘤的攻击性行为有关.
VHL突变突出显示了缺氧和血管生成的作用.
在PTEN,TSC1/TSC2和AKT1-3中发生的突变会破坏mTOR通路,导致PanNET复杂性.

结论:

在PanNETs中的遗传变化显著影响瘤行为和治疗反应.
了解PI3K/AKT/mTOR通路和其他遗传干扰对于开发新型向疗法至关重要.
基于特定遗传特征的向疗法有望改善泛网患者的预后.

关键词:

ATRX ATRX 在线观看 DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXXXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAXX DAX DAX DAX DAX DAX DAX 男人,就是一个人.胰腺癌是一种胰腺癌.这是VHLVHL.在mTOROR中使用mTOR.

更多相关视频

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

相关概念视频

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...